Buchang completes A-share IPO

We are delighted to announce that Buchang completed its A-share IPO on 18 November 2016. The Company listed on the main board of the Shanghai Stock Exchange under the ticker symbol 603858. A link to the news story on the Company’s website can be found here and a link to Buchang’s share price quote can be found here (Bloomberg).


About Buchang Pharmaceuticals

Buchang Pharmaceuticals is one of the leading traditional Chinese medicine (TCM) companies in China. Buchang was founded in 1993 by Mr. Zhao Buchang and his eldest son, Mr. Zhao Tao. Starting as a small TCM drug manufacturer, Buchang has evolved into a sales and marketing powerhouse. The Company has the most extensive sales network amongst its peers in China, covering over 15,000 hospitals and 150,000 drug stores. The Company’s product portfolio consists of in-house developed products, as well as products that it acquired and turned into blockbusters. Buchang’s brand name is widely recognized by physicians and patients throughout China.

Buchang receives CSRC approval for its planned A-share IPO


We are very happy to report that Buchang Pharmaceuticals, China’s leading private traditional Chinese medicine company and a HAO II portfolio company, received listing approval from the China Securities Regulatory Commission (“CSRC”) on 13 July for its planned A-share IPO.

A link to the announcement on the CSRC’s website (in Chinese) can be found here.

LP Amina introduces new coal-upgrading technology at Montana Energy Conference

March 29, 2016 – Billings, MT — LP Amina presented its proprietary technology, BenePlus, on the opening day of the Montana Energy Conference.

Detailed coverage can be found on the Billings Gazette.

About LP Amina

LP Amina is a multinational environmental engineering company with offices in China and the United States. The company was founded in 2007 and since then has evolved from being a niche supplier of advanced pollution control technologies to Chinese coal-fired power plants to an integrated clean energy solutions provider to a wide range of industries globally, including gas-fired power generation, cement, pulp and paper and industrial chemicals. LP Amina’s technology platform consists of poly-generation solutions that co-produce electric power and high-value chemicals and synthetic crude oil, bringing industries together to maximize the efficient use of world’s natural resources.

About the Montana Energy Conference

The Montana Energy Conference is held annually and consists of education sessions and discussions with energy professionals, policy and decision makers at all levels, contractors and associated industry professionals. The event provides an all-encompassing look at Montana’s energy potential.

This news story was original posted on the LP Amina company website here.

HAO Capital Invests US$12.5m in DJ HealthUnion

Daijia logo





Investment to Drive Further Development in DJ HealthUnion’s Health Information Exchange Solutions Technology

Shanghai, Beijing and Hong Kong, 16 Sept 2015 – HAO Capital, the China-focused private equity firm, today announced that it has invested USD 12.5 million in DJ HealthUnion Systems Corporation (“DJ HealthUnion”), a leading domestic provider of digital hospital solutions, with a focus on health data sharing solutions. The financing will be used to further support DJ HealthUnion’s development of its interoperable Health Information Exchange (“HIE”) system.

The investment has been made from HAO’s US$73 million Auxiliary Fund, which was launched in 2014.

DJ HealthUnion has become one of the most established healthcare IT companies in China since its inception in 1999. HAO Capital first invested in DJ HealthUnion in 2010.

With financing and operational support from HAO, DJ HealthUnion has successfully expanded its business from Medical Imaging Informatics to a full range of digital hospital solutions, and developed an IP-protected Health Information Exchange (“HIE”) Solution called the Health Information Union Platform (“HiUP”) series. HiUP meets the national and global standards of healthcare IT (“HCIT”) interoperability, a foundation enabling different IT system software applications to exchange information and then meaningfully use the information received.

Qian Weijia, General Manager and CEO of DJ HealthUnion, said, “More and more hospitals in China have multiple HCIT systems, which hold valuable clinical data but simply cannot share it with each other to support clinical decision-making, coordinated care, quality improvement and efficiency. The need for effective data sharing within and among hospitals has rapidly increased in recent years. HiUP is the first HIE system developed in China that can best meet such needs. Mobile and big data applications in the healthcare industry have also become new drivers of health data sharing, which has created even greater potential for HiUP.

“Our self-developed HiUP series of HIE solutions have been successfully applied by some of the leading hospitals and regional union projects in Guangzhou, Suzhou, Shanghai, Beijing and Jinan. With further support from HAO Capital, we are confident of increasing our technical and implementation capability for a nationwide client base, with a mission to provide cost efficient solutions to healthcare providers and to create a better patient experience.”

Elaine Wong, Partner and Co-Founder of HAO Capital, said, “DJ HealthUnion is unique in China, bringing together a team of Healthcare, Hospital Management, and IT experts and we are delighted to be funding its further development. Its HiUP is the first full HIE system in China providing hospital administrators with a real-time dashboard to understand and improve the speed, quality, safety, and cost of hospital-wide patient care. It also enables doctors to secure real-time access to patient data, not only providing information at their fingertips, but directly improving the speed and efficiency of patient care.”

DJ HealthUnion’s unique HiUP system has helped the First Affiliated Hospital of Sun Yat-sen University in Guangzhou fully digitalize its medical records and enabled the hospital to efficiently use all patient information across the various different departments within the hospital. It has not only revolutionized its data management but has also laid the foundation for the hospital to conduct in-depth data analysis in the future.

DJ HealthUnion is part of SKR, HAO Capital’s medical technology platform company. The company’s vision is to become a leading medical equipment, service and solution provider that makes quality healthcare accessible and affordable to patients in China.

SKR has made three key investments to date: AMS (a radiopharmaceutical provider), TCL Healthcare (a medical diagnostic imaging company), and DJ HealthUnion.

HAO Capital: one of the top 50 foreign PE companies in China

Screen Shot 2015-01-23 at 3.04.13 pm

HAO Capital has been recognized as a top 50 foreign private equity company in China in 2014. This is the third consecutive year HAO has won this accolade at the China Venture Capital & Private Equity Awards.

The awards are organized by Zero2IPO, a leading Chinese PE/VC industry information provider. They evaluate thousands of active PE/VC players in China on their performance with respect to fund raising, investment, portfolio management and exit activities.

For more information, please click here.

HAO Capital participates in third round funding for Wanxue Education


HAO Capital, the China-focused private equity firm, today announced that an entity controlled by funds managed by HAO Capital has acquired a minority stake in Beijing Wanxue Education Technology Limited (“Wanxue”), alongside co-investors Baidu and DCM. The third round financing will be used to further grow Wanxue’s online education business and promote the development of its cloud-based learning portal.

Wanxue is the leading educational institution for professional and academic training for college students in China. Established in 2006, Wanxue is the #1 CGAT (China Graduate Admission Test) test preparation training school in China. The company specializes in preparation courses for post-graduate entrance exams and civil service exams which it offers in 25 provinces, regions, and municipalities across China.

Wanxue has a mission to be the leading one-stop learning partner and mentor for college students and advance degree holders in China. Today, the company provides innovative one-stop online and offline hybrid test preparation services that will further enlarge its addressable market. The Series C financing will enable the company to significantly enhance its online marketing and O2O (“online to offline”) capacity.

Kenneth Yan, Principal of HAO Capital, said, “Wanxue is representative of the education industry’s future. It has a market-leading position in China and is the recognized leader with an impressive track record in market share, service quality and technology. With its nation-wide coverage and established technology we are confident that Wanxue is well-placed to address the growing demand for online education.”

About Wanxue

Beijing Wanxue Education Technology Co., Ltd. provides educational services in China. The company offers test preparation services for entrance examination for graduate studies; and admission consulting services to students at university level and above. Beijing Wanxue Education Technology Co., Ltd. was founded in 2006 and is based in Beijing, China.